We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Hemoglobin A1c Preferred to Glucose for Diabetes Diagnosis

By LabMedica International staff writers
Posted on 27 Jul 2009
Hemoglobin A1c (HbA1c) was an accepted and reliable measure of long-term glycemic control in diabetics, whereas glucose has been the "gold standard” for diabetes diagnosis. More...
Chemical societies and laboratories have to deal with a surprising recommendation to measure HbA1c rather than glucose for diagnosis of diabetes.

The new recommendation was discussed at the American Association for Clinical Chemistry's (AACC) 2009 annual meeting, which was held in Chicago, IL, (USA) from July 19-23, 2009. A seminar at the meeting focused on the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) criteria for screening and diagnosing diabetes; the ADA criteria for diagnosing diabetes in pregnant women; and the use of handheld glucose meters in intensive care unit (ICU) patients.

Dr. David B. Sacks, from Brigham and Women's Hospital (Boston, MA, USA), reported that the new recommendation to measure HbA1c rather than glucose for diagnosis of diabetes is a major departure from all prior guidelines. He said, "Although the specific details of the recommendations to be proposed by these bodies have not been decided, it appears highly likely that all of the major clinical diabetes organizations will adopt HbA1c measurement for the diagnosis of diabetes.”

Related Links:

Brigham and Women's Hospital



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.